Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 351 Records) |
Query Trace: Chronic Myeloid Leukemia[original query] |
---|
Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing. Cytogenetic and genome research 2022 9 162 (4): 201-206. Abulaiti Dilinazi, Tuerxun Niluopaer, Wang Huan, Abulizi Patiguli, Zhao Fang, Liu Yang, Hao Jianpi |
Update meta-analysis from biomedical literature about MTHFR'polymorphisms and the CML' risk. La Tunisie medicale 2022 9 100 (4): 285-294. Turki Fatma, Louati Nour, Kamoun Hassen, Keskes Leila, Rebaii Tarek, Frikha R |
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 842-846. Tarantini Francesco, Cumbo Cosimo, Zagaria Antonella, Parciante Elisa, Anelli Luisa, Coccaro Nicoletta, Tota Giuseppina, Minervini Crescenzio Francesco, Redavid Immacolata, Rossi Antonella Russo, Conserva Maria Rosa, Specchia Giorgina, Musto Pellegrino, Albano Frances |
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia. Medicina (Kaunas, Lithuania) 2022 Aug 58 (8): . Provenzano Aldesia, Chetta Massimiliano, De Filpo Giuseppina, Cantini Giulia, La Barbera Andrea, Nesi Gabriella, Santi Raffaella, Martinelli Serena, Rapizzi Elena, Luconi Michaela, Maggi Mario, Mannelli Massimo, Ercolino Tonino, Canu Letiz |
Genetic counseling and carrier screening in candidates for gamete donation at a Portuguese center. JBRA assisted reproduction 2022 8 . Soares Célia Azevedo, Tkachenko Natália, Vale-Fernandes Emídio, Barreiro Márcia, Abreu Maria, Reis Cláudia Falcão, Soares Gabriela, Fortuna Ana Maria, Soares Ana Ri |
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia 2022 7 36 (9): 2242-2249. Schönfeld Lioba, Rinke Jenny, Hinze Anna, Nagel Saskia N, Schäfer Vivien, Schenk Thomas, Fabisch Christian, Brümmendorf Tim H, Burchert Andreas, le Coutre Philipp, Krause Stefan W, Saussele Susanne, Safizadeh Fatemeh, Pfirrmann Markus, Hochhaus Andreas, Ernst Thom |
Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation. Folia medica 2022 7 63 (5): 670-675. Goranova-Marinova Veselina, Linev Alexander, Ivanov Hristo J, Zheljazkov Ivan, Stoyanova Vily, Grudeva-Popova Zhan |
Correction: HLA Polymorphisms Are Associated With Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Molecular cancer therapeutics 2022 May 21 (5): 855. Ureshino Hiroshi, Shindo Takero, Tanaka Hidenori, Saji Hiroh, Kimura Shin |
Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemia. Pediatric blood & cancer 2022 5 69 (9): e29786. Dong Elizabeth E, Bruno Michael A, Kim Jeffrey J, Bernhardt Melanie B, Brown Austin L, Gramatges Maria |
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia. The Journal of molecular diagnostics : JMD 2022 5 24 (7): 803-822. Shanmuganathan Naranie, Wadham Carol, Thomson Daniel, Shahrin Nur Hezrin, Vignaud Chloe, Obourn Vanessa, Chaturvedi Shalini, Yang Feng, Feng Jinghua, Saunders Verity, Kok Chung H, Yeung David, King Rob M, Kenyon Rosalie R, Lin Ming, Wang Paul, Scott Hamish, Hughes Timothy, Schreiber Andreas W, Branford Sus |
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation. Hematological oncology 2022 4 40 (3): 442-456. Shimazu Yutaka, Murata Makoto, Kondo Takeshi, Minami Yosuke, Tachibana Takayoshi, Doki Noriko, Uchida Naoyuki, Ozawa Yukiyasu, Yano Shingo, Fukuda Takahiro, Kato Jun, Ara Takahide, Eto Testuya, Ishikawa Jun, Nakamae Hirohisa, Tanaka Junji, Ichinohe Tatsuo, Atsuta Yoshiko, Nagamura-Inoue Tokiko, |
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies. Molecular diagnosis & therapy 2022 4 26 (3): 333-343. Bhai Pratibha, Hsia Cyrus C, Schenkel Laila C, Hedley Benjamin D, Levy Michael A, Kerkhof Jennifer, Santos Stephanie, Stuart Alan, Lin Hanxin, Broadbent Robert, Nan Shirley, Yang Ping, Xenocostas Anargyros, Chin-Yee Ian, Sadikovic Bek |
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood cancer journal 2022 4 12 (4): 69. Adnan Awad Shady, Brück Oscar, Shanmuganathan Naranie, Jarvinen Timo, Lähteenmäki Hanna, Klievink Jay, Ibrahim Hazem, Kytölä Soili, Koskenvesa Perttu, Hughes Timothy P, Branford Susan, Kankainen Matti, Mustjoki Sa |
Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Experimental hematology & oncology 2022 3 11 (1): 13. Shi Ting, Xie Mixue, Chen Li, Yuan Wei, Wang Yungui, Huang Xin, Xie Wanzhuo, Meng Haitao, Lou Yinjun, Yu Wenjuan, Tong Hongyan, Ye Xiujin, Huang Jinyan, Jin Jie, Zhu Hong |
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation. Cancer chemotherapy and pharmacology 2023 8 . Shiyu He, Qianhang Shao, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Yuanyuan Li, Lei Hu, Boyu Liu, Huan He, Lin Huang, Qian Jia |
Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment. Cancers 2023 7 15 (13): . Ruth Stuckey, Adrián Segura-Díaz, María Nieves Sáez Perdomo, Manuel Mateo Pérez Encinas, Jóse David González San Miguel, Yanira Florido, Santiago Sánchez-Sosa, Juan Francisco López-Rodríguez, Cristina Bilbao-Sieyro, María Teresa Gómez-Casares, |
Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia. Leukemia research 2023 6 131 107325. Macario Martínez-Castillo, Laura Gómez-Romero, Hugo Tovar, Irma Olarte-Carrillo, Anel García-Laguna, Gilberto Barranco-Lampón, Adrián De la Cruz-Rosas, Adolfo Martínez-Tovar, Araceli Hernández-Zavala, Emilio J Córdo |
Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (Bcl-2/Bax) and Proinflammatory Cytokine (TNF-?/IL-8) Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study. Current issues in molecular biology 2023 5 45 (5): 3933-3952. Mamdoh S Moawadh, Rashid Mir, Faris J Tayeb, Orooba Asim, Mohammad Fahad Ull |
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention. Haematologica 2023 3 . Shanmuganathan Naranie, Wadham Carol, Shahrin NurHezrin, Feng Jinghua, Thomson Daniel, Wang Paul, Saunders Verity, Kok Chung Hoow, King Rob M, Kenyon Rosalie R, Lin Ming, Pagani Ilaria S, Ross David M, Yong Agnes S M, Grigg Andrew P, Mills Anthony K, Schwarer Anthony P, Braley Jodi, Altamura Haley, Yeung David T, Scott Hamish S, Schreiber Andreas W, Hughes Timothy P, Branford Sus |
Haplotype-GGGT in long non-coding RNA MALAT1 inhibits brain metastatic lung cancer and lymph nodes of lung cancer via the MALAT1/miR-328/KATNB1. Aging 2023 3 15 . Liu Tingting, Ma Jianpeng, Hou Dongmei, Wang Weiqi, Cao Het |
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 2023 2 24 (4): . Dalle Fratte Chiara, Polesel Jerry, Gagno Sara, Posocco Bianca, De Mattia Elena, Roncato Rossana, Orleni Marco, Puglisi Fabio, Guardascione Michela, Buonadonna Angela, Toffoli Giuseppe, Cecchin Eri |
Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study. Saudi journal of biological sciences 2023 12 31 (1): 103882. Zahraa A Abdulrazaq, Mushtak T S Al-Ouqaili, Nabeel M Tal |
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 2023 12 . Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim H Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Satu Mustjoki, Edgar Faber, Jiri Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kami?ska, Magdalena P?onka, El?bieta Szczepanek, Monika Szarejko, Gra?yna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiob?dzka-Kr??el, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saußele, Markus Pfirrma |
The causal relationship between gut microbiota and leukemia: a two-sample Mendelian randomization study. Frontiers in microbiology 2023 12 14 1293333. Guanjun Chen, Zheshu Kuang, Fan Li, Jianchang |
Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib. Geriatrics & gerontology international 2023 11 . Yusuke Nakamura, Daisuke Hidaka, Reiki Ogasawara, Kohei Okada, Junichi Sugita, Ayumi Sukehata, Kohime Kitagawa, Shuichi Ota, Masahiro Imamu |
Association of ABCB1, ABCG2 drug transporter polymorphisms and smoking with disease risk and cytogenetic response to imatinib in chronic myeloid leukemia patients. Leukemia research 2023 1 126 107021. Mohammadi Fatemeh, Rostami Golale, Hamid Mohammad, Shafiei Mohammad, Azizi Masoumeh, Bahmani Has |
A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients. Drug research 2023 1 73 (3): 146-155. Sabri Alaa, Omran Mervat M, Azim S Abdel, Abdelfattah Raafat, Allam Rasha Mahmoud, Shouman Samia |
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Annals of diagnostic pathology 2024 4 71 152317. Seon Young Kim, Ik-Chan Song, Jimyung Kim, Gye Cheol Kw |
Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia. International immunopharmacology 2024 4 133 112090. Fang Cheng, Zheng Cui, Qiang Li, Shi Chen, Weiming Li, Yu Zha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: